Studies prove you are more likely to die if they make you wait.
Tomas Philipson 15, Ph.D, is an economist who holds the Daniel Levin Chair in Public Policy at The University of Chicago, 10-7-2015, "Plan Restrictions On Doctors and Patients: Do We Want Centralized Or Decentralized Medicine?," Forbes, https://www.forbes.com/sites/tomasphilipson/2015/10/07/plan-restrictions-on-doctors-and-patients-do-we-want-centralized-or-decentralized-medicine/2/#4fb1ba7b5f71
The fact that ST makes patients pay with their time rather than their money is cause for significant concern, as a substantial body of evidence shows that delays in treatment harm patients with a wide array of conditions. For example, a study published in The Lancet found that patients with delays of three months or more in treatment had a 12% lower five-year survival rate than those with shorter delays. Similarly, another study published in the American Journal of Medicine found that rheumatoid arthritis patients who delayed disease-modifying treatment for approximately four months experienced significantly more radiologic joint damage after two years compared to patients who began treatment within two weeks of diagnosis.